HIGHLIGHTS
- who: Cencioni. Neuroimmunol, Neuroinflammation and Neuroimmunology, from the Division of clinical neurology, Brain Sciences department, Imperial College London, London , NN, UK have published the research work: Neuroimmunology and Neuroinflammation, in the Journal: (JOURNAL)
- what: PD-1 is an immune checkpoint inhibitor demonstrated to reduce the immune system response in cancer and chronic infection.
- how: This review describes the roles of the PD-1/ PDL-1 pathway in cancer and autoimmune diseases especially in multiple sclerosis and how manipulating PD-1 can be a therapeutic approach in multiple sclerosis. Analysis of the data showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.